Cresco Labs: Haywood Marginally Revises Estimates Following Cultivate Acquisition

On September 3, Cresco Labs (CSE: CL) announced that they have closed their acquisition of Cultivate, a vertically integrated Massachusetts operator that was acquired for $90 million, plus a potential $68 million earn-out. Cultivate currently operates roughly 42,000 square feet of active canopy with an additional 20,000 square feet of canopy available for build-out. The company has 3 open dispensaries.

Cresco Labs currently has 17 analysts covering the name with an average 12-month price target of $23.97, or a 104% upside. Out of the 17 analysts, 5 have strong buy ratings, 11 have buy ratings and 1 analyst has a hold rating. The street high sits at $34 from Stifel-GMP while the lowest comes in at $18.

Haywood Capital Markets, which has a $12 price target and buy rating, says they have updated their 2021 and 2022 estimates as the acquisition has closed ahead of time. They write, “The expanded Massachusetts operations should position the Company to capitalize on the rapidly growing market.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Haywood says that the deal when announced represented a 4-4.5x 2021 EV/EBITDA multiple factoring in the $68 million earnouts. Additionally, of the $75 million in shares issued, 68% will have a 4/8/12 month vesting schedule.

They give some background on the Massachusetts market. The market went adult-use back in November of 2018 and has done little over $2 billion in sales since then. With $702 million in sales in 2020 and $844 million year-to-date, that implies a sales run-rate of $1.25 billion and an 80% growth year over year.

Below you can see Haywood’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Facebook: BMO Raises Price Target To $425

On July 28, Facebook (NASDAQ: FB) reported their second quarter earnings, continuing the trend of...

Sunday, August 1, 2021, 02:08:00 PM

Ayr Wellness: Canaccord Reiterates $70 Price Target Following Earnings

Earlier this week, Ayr Wellness (CSE: AYR.a) reported their first-quarter earnings. The company reported revenues...

Friday, May 28, 2021, 04:02:00 PM

BMO Reiterates Targets On Couche-Tard Despite Q2 Earnings Beat

On August 30, Alimentation Couche-Tard Inc. (TSX: ATD.B) announced its fiscal first quarter financial results...

Friday, September 2, 2022, 03:02:00 PM

Meta Platforms: Canaccord Anticipates Headwinds To Persist, Cuts Target To $200

On October 26th, Meta Platforms Inc (Nasdaq: META) reported its third-quarter financial results. The company...

Thursday, November 3, 2022, 12:52:00 PM

Canaccord Reiterates $70 Price Target On Ayr Wellness Following New Jersey Acquisition

On September 16, Ayr Wellness (CSE: AYR.a) closed their Garden State Dispensary acquisition, a New...

Tuesday, September 21, 2021, 03:42:00 PM